Nasal administration of retinal antigens maintains immunosuppression of uveoretinitis in cyclosporin-A-treated Lewis rats: Future treatment of endogenous posterior uveoretinitis?

Eye

Volumn 11, Issue 4, 1997, Pages 445-452

  Kreutzer, Bernhard ^a   Laliotou, Barbara ^a   Cheng, Y F ^a   Liversidge, Janet ^a   Forrester, John V ^a   Dick, Andrew D ^a  

^a UNIVERSITY OF ABERDEEN   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

AUTOANTIGEN; CYCLOSPORIN A; IMMUNOSUPPRESSIVE AGENT; RETINA ANTIGEN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; AUTOIMMUNITY; CONTROLLED STUDY; DISEASE SEVERITY; DOSE RESPONSE; DOSE TIME EFFECT RELATION; DRUG TOXICITY; ETIOLOGY; FEMALE; GASTROINTESTINAL MUCOSA; HISTOPATHOLOGY; IMMUNOSUPPRESSIVE TREATMENT; INTRANASAL DRUG ADMINISTRATION; NONHUMAN; ORAL DRUG ADMINISTRATION; RAT; RELAPSE; RESPIRATORY TRACT MUCOSA; RETINA ROD OUTER SEGMENT; THERAPY; UVEORETINITIS;

EID: 0030866374     PISSN: 0950222X     EISSN: None     Source Type: Journal    
DOI: 10.1038/eye.1997.125     Document Type: Article

References (33)

1. Forrester JV. Duke Elder Lecture. New concepts on the role of autoimmunity in the pathogenesis of uveitis. Eye 1992;6:433-7.
2. Gery I, Mochizuki M, Nussenblatt RB. Retinal specific antigens and the immunopathologic mechanisms they provoke. Prog Retinal Res 1986;5:75-109.
3. Towler HM, Whiting P, Forrester JV. Combination of low dose CsA and steroid therapy of chronic intraocular inflammation. Eye 1990;4:514-20.
4. Towler HM, Forrester JV, Lightman SL. Low dose CsA therapy of ocular inflammation: preliminary report of a long term follow up study. Autoimmunity 1992;5:259-64.
5. Ishioka M, Ohno S, Nakamura S, Isobe K, Watanabe N, Ishigatsubo Y, Tanaka S. FK 506 treatment of non-infectious uveitis. Am J Ophthalmol 1994;118:723-30.
6. Isaacs J, Dick AD, Haynes RH, Watson P, Meyer PAR, Forrester JV, et al. Monoclonal antibody therapy of chronic intraocular inflammation using CAMPATH-1H. Br J Ophthalmol 1995;79:1054-5.
7. Caspi RR, Roberge FG, McAllister CG, El-Saied M, Kuwabara T, Gery I, Hanna E, Nussenblatt RB. T cell lines mediating experimental autoimmune uveitis in the rat. J Immunol 1986;136:928-33.
8. + T cells in the inflamed eye. Ocul Immunol Inflam 1995;3:261-70.
9. Forrester JV, Liversidge J, Dua HS, Towler H, McMenamin PG. Comparison of clinical and experimental uveitis. Curr Eye Res 1990;9:75-84.
10. Dick AD. Experimental approaches to specific immunotherapies in autoimmune disease: future treatment of endogenous posterior uveitis. Br J Ophthalmol 1995;79:81-8.
11. Forrester JV, Liversidge J, Dua HS, Dick A, Harper F, McMenamin PG. Experimental autoimmune uveoretinitis: a model system for immunosuppression: a review. Curr Eye Res 1992;11:33-42.
12. Nussenblatt RB, Rodrigues MM, Wacker WB, Cevario SJ, Salinas-Camara MC, Gery I. Cyclosporin A: inhibition of experimental autoimmune uveitis in Lewis rat. J Clin Invest 1981;67:1228-332.
13. Nussenblatt RB, Caspi RR, Mahdi R, Chan CC, Roberge F, Lider O, Weiner HL. Inhibition of S-Ag induced experimental autoimmune uveoretinitis by oral induction of tolerance with S-antigen. J Immunol 1990;144:1689-95.
14. Vrabec TR, Gregerson DS, Dua HS, Donoso LA. Inhibition of experimental autoimmune uveoretinitis by oral induction of tolerance with S-Ag and synthetic peptides. Autoimmunity 1992;12:175-84.
15. + cells. J Immunol 1988;142:748-53.
16. Thompson HSG, Harper N, Bevan DJ, Staines NA. Suppression of collagen induced arthritis by oral administration of type II collagen: changes in immune and arthritis responses mediated by active peripheral suppression. Autoimmunity 1993;16:189-99.
17. Weiner HL, Mackin GA, Matsui M, Orav EJ, Khoury SJ, Dawson DM, Haffler DA. Double blind pilot trial of oral tolerisation with myelin antigens in multiple sclerosis (see comments). Science 1993;259:1321-4.
18. Holt PG, Sedgwick JD. Suppression of IgE responses following inhalation of antigens. Immunol Today 1987;8:14-5.
19. Dick AD, Cheng Y, Liversidge J, McKinnon A, Forrester JV. Nasal administration of retinal antigens suppresses the inflammatory response in experimental autoimmune uveoretinitis: a preliminary report of intranasal induction of tolerance with retinal antigens. Br J Ophthalmol 1993;77:171-9.
20. Dick AD, Cheng YF, Liversidge J, Forrester JV. Immunomodulation of experimental autoimmune uveoretinitis: a model of tolerance induction with retinal antigens. Eye 1994;8:52-9.
21. Dick AD, Cheng YF, Liversidge J, Forrester JV. Intranasal administration of retinal antigens suppresses retinal antigen induced experimental autoimmune uveoretinitis. Immunology 1994;82:625-31.
22. Kennedy MK, Tan LJ, DalCanto MC, Tuohy VK, Lu A, Trotter JL, Miller SD. Inhibition of murine relapsing EAE by immune tolerance to proteolipid protein and its encephalogenic peptides. J Immunol 1990;145:909-15.
23. Chen Y, Imobe I, Kichroo VK, Baron JL, Janeway CA Jr, Weiner HL. Oral tolerance in MBP T cell receptor transgenic mice: suppression of autoimmune encephalomyelitis and dose dependent induction of regulatory cells. Proc Natl Acad Sci USA 1996;93:338-91.
24. Dick AD, McMenamin PG, Korner H, Scallon BJ, Ghrayeb T, Forrester JV, Sedgwick JD. Inhibition of tumour necrosis factor-activity minimises target-organ damage in experimental autoimmune uveoretinitis despite quantitatively normal activated T cell traffic to the retina. Eur J Immunol 1996;26:1018-25.
25. Laliotou B, Liversidge J, Forrester JV, Dick AD. Interphotoreceptor retinoid binding protein (IRBP) is a potent tolerogen in Lewis rat: suppression of experimental autoimmune uveoretinitis (EAU) is retinal antigen specific. Br J Ophthalmol 1997; 81:61-7.
26. Gregerson DS, Obritsch WF, Donoso LA. Oral tolerance in experimental autoimmune uveoretinitis: distinct mechanisms of resistance are induced by low dose vs high dose feeding protocols. J Immunol 1993;151:5751-61.
27. Sedgwick JD, Holt PG. Induction of IgE-secreting cells and IgE isotype specific suppressor cells in the respiratory tract lymph nodes of rats in response to antigen inhalation. Cell Immunol 1985;94:182-90.
28. Khoury SJ, Hancock WW, Weiner HL. Oral tolerance to myelin basic protein and natural recovery from experimental autoimmune encephalomyelitis are associated with downregulation of inflammatory cytokines and differential upregulation of transforming growth factor, interleukin 4, and prostaglandin E expression in the brain. J Exp Med 1992;176:1355-64.
29. Rizzo LV, Miller-Rivero NE, Chan CC, Wiggert B, Nussenblatt RB, Caspi RR. Interleukin-2 treatment potentiates induction of oral tolerance in a murine model of autoimmunity. J Clin Invest 1994;94:1668-72.
30. Higuchi M, Diamantstein T, Osawa H, Caspi RR. Combined anti-interleukin 2 receptor and low dose cyclosporine therapy in experimental autoimmune uveoretinitis. J Autoimmun 1991;4(1):113-24.
31. McMenamin C, Primm C, McKersey M, Holt PG. Regulation of IgE responses to inhaled antigens in mice by antigen-specific gamma-delta T cells. Science 1994;265:1869-70.
32. Wildner G, Kuhnlein P, Hunig T, Thurau SR. The role of gamma-delta T cells in induction and suppression of experimental autoimmune uveitis. Presented at the Joint European Research Meetings in Ophthalmology and Vision, Montpellier, France, October 1995. Abstract published in Vision Res 1995;35(Suppl):S113.
33. Wildner G, Kuhnlein P, Hunig T, Thurau SR. The role of gamma-delta T cells in induction and suppression of experimental autoimmune uveitis. Presented at the Joint European Research Meetings in Ophthalmology and Vision, Montpellier, France, October 1995. Abstract published in Vision Res 1995;35(Suppl):S113.